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were measured by radioimmunoassay (Amersham RPA525; 
Amersham International Ltd., Little Chalfont, U.K.). Arte- 
rial cGMP concentrations and the mean pulmonary arterial- 
systemic arterial pressure ratios, recorded with and without 
INO, are shown in Fig. 1. 
Our results show that although the cGMP concentra- 
tions increased with the commencement of INO, levels 
appeared to fall below baseline when attempts were 
made to wean the patient from INO during the first 6 
days of its administration. After 6 days of INO therapy, 
discontinuation of the INO was no longer associated 
with a fall in cGMP concentrations; this coincided with 
clinical resolution of the pulmonary hypertension, sug- 
gesting that spontaneous recovery of endogenous NO 
production had occurred. The patient was extubated 1
day later and was discharged home after 4 more days. 
We believe that these results support he hypothesis 
that exogenous INO suppresses endogenous NO pro- 
duction after cardiopulmonary bypass when known 
reversible endothelial damage has occurred. 4 Exoge- 
nous NO has been shown to suppress endogenous NO 
production in the rat cerebellum by inhibiting nitric 
oxide synthetase, the rate-limiting enzyme of NO pro- 
duction. 5Our findings indicate that similar changes may 
be occuring in the pulmonary endothelium. An alterna- 
tive explanation could be that the falling concentrations 
of cGMP are the result of disease of the pulmonary 
endothelium, which is ongoing and was itself the initial 
cause of the pulmonary hypertension. 
In conclusion, exogenous INO may suppress endog- 
enous NO production by the pulmonary endothelium 
during the early course of its administration. This has a 
number of important clinical implications. First, regular 
reverse dose-response studies should be conducted to 
allow the patient o be gradually weaned from INO as 
clinical improvement and endothelial recovery 
progress, because rebound pulmonary hypertension 
may occur if INO treatment is discontinued abruptly. 
Second, patients already receiving INO who require 
transfer to tertiary centers may require the INO admin- 
istration to be continued uring the transport. Finally, 
although prophylactic INO administration may be con- 
sidered in patients at high risk, its administration may 
lengthen the time required for mechanical ventilation. 
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EVANS BLUE AND GENTIAN VIOLET: ALTERNATIVES TO METHYLENE BLUE AS A SURGICAL 
MARKER DYE 
Kanili Shoemaker, a Joseph Rubin, MD, b G. Lionel Zumbro, MD, c and Randall Tackett, PhD, a 
Athens and Augusta, Ga. 
Dyes, such as methylene blue, are used during vascular 
surgery to aid in the visualization and orientation of the 
blood vessel. Although methylene blue dye is believed to 
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be innocuous, we I recently demonstrated that extravascu- 
lar application of 1% methylene blue impairs both endo- 
thelium-dependent a d endothelium-independent vasore- 
laxation. The present study investigated Evans blue and 
gentian violet as alternative surgical marker dyes to 
methylene blue. 
Human saphenous veins were cut into 2 to 4 mm rings, 
carefully swabbed with 0.5% Evans blue, 1.0% gentian 
violet, or Krebs buffer, and incubated in 20 ml of buffer at 
25 ° C for 45 minutes. The vascular ings were then sus- 
pended in 10 ml tissue baths containing Krebs buffer, and 
dose-response curves to acetylcholine, isoproterenol, ve 
rapamil, and sodium nitroprusside were performed as 
previously described. 1 
Vascular ings were assayed in duplicate and averaged 
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Fig. 1. The effect of Evans blue (EB) exposure on vaso- 
dilator activity in saphenous veins. Control ring prepara- 
tions were swabbed with Krebs buffer. Responses are 
expressed as a percentage of phenylephrine (10 -5 mol/L). 
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Fig. 2. The effect of gentian violet (GV) exposure on 
vasodilator activity in saphenous veins. Control ring prep- 
arations were swabbed with Krebs buffer. Responses are 
expressed as a percentage of phenylephrine (10 .5 mol/L). 
*p < 0.05. 
to yield a single n value. All statistical analyses were 
performed with the n values representing the number of 
patients. Differences were assayed by a one-way analysis 
of variance followed by a Bonferroni t test for multiple 
comparisons. All data are presented as the mean _+ 
standard error of the mean. Only differences with a p 
value < 0.05 were deemed as statistically significant. 
Potassium chloride (70 mmol/L) produced a contrac- 
tion of 1.45 + 0.36 gm in control rings, which was not 
significantly different from that observed in rings sub- 
jected to Evans blue (1.92 + 0.48 gm) or gentian violet 
(1.81 -+ 0.40 gm). Phenylephrine (10 -s mol/L) also pro- 
duced a comparable constriction (1.73 + 0.52 gin), which 
was unaffected by exposure to either Evans blue or 
gentian violet-treated tissue. 
Acetylcholine, which assessed endothelium-dependent 
responses, produced a dose-dependent vasodilation with 
the nadir at -54% -4- 11%, which was unaffected by 
exposure to Evans blue (Fig. 1, A). Sodium nitroprusside 
was used to assess endothelium-independent vasodilation. 
As seen in  Fig. 1, B, 100% relaxation was achieved in 
response to,sodium nitroprusside in control vein segments 
and segments exposed to Evans blue. Verapamil was used 
to assess calcium-mediated responses. As seen in Fig. 1, C, 
no significant differences were noted between control 
vessels and those treated with Evans blue. Fig. 1, D, shows 
that the vasodilatory responses to isoproterenol mediated 
through/32-adrenergic receptors was unaffected by Evans 
blue treatment. 
Gentian violet treatment did not affect the vasodilatory 
responses to acetylcholine (Fig. 2, A), verapamil (Fig. 2, 
C), or isoproterenol (Fig. 2, D). However, gentian violet 
inhibited the vasodilatory response to sodium nitroprus- 
side, as seen in panel B of Fig. 2. 
The present study demonstrates that Evans blue does 
not impair either endothelium-dependent or endothelium- 
independent vasodilation. Alternatively, gentian violet im- 
paired only the endothelial response to sodium nitroprus- 
side, and this degree of impairment was greater than that 
previously reported with the use of methylene blue dye. l 
Methylene blue dye has several actions that could 
adversely affect vascular reactivity, including inhibition 
of soluble guanylate cyclase 2 and production of super- 
oxide. 3 
The pharmacologic actions of Evans blue and gentian 
violet have not been studied extensively and thus remain 
relatively poorly understood. Gentian violet is best known 
as a topical antimicrobial agent that irreversibly binds 
microbial deoxyribonucleic acid and directly inhibits rep- 
lication. 4 Evans blue is a biologic stain whose pharmaco- 
logic effects have not been extensively studied, but it is 
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commonly used as a diagnostic agent for the determina- 
tion of plasma volume. 5
The reason for inhibition of the sodium nitroprusside 
response by gentian violet is unclear. Gentian violet is 
metabolized to a reactive intermediate or free radical that 
could act at the vascular smooth muscle to inhibit the 
response. However, this is unlikely inasmuch as this 
mechanism would also interfere with the acetylcholine- 
mediated vasodilation. A more plausible explanation 
would be the formation of a reactive intermediate that 
interacts directly with the sodium nitroprusside molecule. 
In conclusion, although methylene blue has been used as 
a marker dye, our studies uggest that it is inappropriate for 
marking vascular grafts. Evans blue did not adversely affect 
vasodilation to any agent and thus could be used as an 
alternative to methylene blue without fear of affecting raft 
reactivity. Gentian violet also appears to be a better alternate 
to methylene blue. However, we did observe a decrease in 
endothelium-independent vasodilation, a factor that should 
be considered when this agent is used. 
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EROSION OF INLET CANNULA OF LEFT VENTRICULAR ASSIST DEVICE MANIFESTED AS 
INNOCUOUS BLEEDING IN STABLE PATIENT: LESSONS LEARNED IN PREVENTION OF 
CATASTROPHIC CONSEQUENCES 
Sanjay M. Mehta, MD, and Walter E. Pae, Jr., MD, Hershey, Pa. 
We present the case of a patient who underwent 
implantation of a left ventricular assist device (LVAD) as 
a bridge to transplantation a d subsequently had disrup- 
tion of the Dacron inflow graft of the pump. Surgical 
investigation at the development of expanding hematoma 
and drive line bleeding resulted in entrainment of air into 
the pump, massive air embolus, and subsequent death of 
the patient. We believe that this case demonstrates the 
need for angiographic definition of bleeding associated 
with a completely implanted LVAD before surgical explo- 
ration, as well as specific surgical strategies to avoid air 
embolus. 
A 64-year-old man was admitted to our institution with 
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a history of progressive cardiac failure. He had had aortic 
valve replacement with a porcine prosthesis and implan- 
tation of a pacemaker 7 years before this admission. An 
extensive valuation indicated end-stage dilated cardio- 
myopathy. The patient was activated on the waiting list for 
cardiac transplantation. Despite a regimen of dopamine, 
dobutamine, amrinone, and intravenous diuretics, the 
patient had progressive symptoms of cardiac failure. An 
intraaortic balloon pump was inserted, with only marginal 
improvement in hemodynamics. Despite this aggressive 
conventional management, he patient had progressive 
deterioration and thus underwent preperitoneal implan- 
tation 1'2 of the Thermo Cardiosystems Incorporated 
(TCI) Heartmate LVAD (Woburn, Mass.) 2 months after 
admission. The initial postoperative course was unevent- 
ful except for transient failure of the right side of the 
heart, responsive to dopamine, during the first postoper- 
ative week and thoracentesis on two occasions in the early 
postoperative course for recurrent left pleural effusion 
with drainage on each occasion of approximately 1 L of 
serous fluid. On postoperative day 32 the patient was 
evaluated on an emergency basis for brisk bleeding 
around the drive line site, and physical examination 
confirmed an expanding collection of fluid within the 
preperitoneal implantation pocket. The patient was 
promptly taken to the operating room for suspected 
bleeding within the preperitoneal pocket. The preperito- 
